StocksBristol-Myers Squibb CoBMY

BMY

Bristol-Myers Squibb Co

70.36 0.21 (0.30%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
70.20
B
70.44

Overview

Prev Close70.36
Day's Range 70.08 - 71.38
52 Week Range 53.17 - 80.50
Average Volume (3m)9.68M
1-Year Return17.46%
Beta0.5135
Market Cap150.24B
P/E Ratio23.38
Revenue47.14B
EPS3.01
Dividend (Yield)2.16 (3.07%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.713/04/202229/06/202208/09/202267.5070.0072.5075.0077.5080.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Giovanni Caforio, MD
Employees 32,200

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Bristol-Myers Squibb Co's revenues increased by 9.09% and amounted to 46.39B. Net income decreased by NaN to N/A. Net assets decreased by NaN to N/A and EPS increased from -3.99 to 3.12.
BMY's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
58.36%
Net Profit Margin
6.74%
Operating Margin
19.87%
Return On Investment
6.55%
09/21
12/21
03/22
06/22
Total Revenue
11.62B
11.99B
11.65B
11.89B
Gross Profit
9.33B
N/A
6.76B
9.31B
Operating Income
2.56B
6.99B
2.71B
2.81B
Net Income
1.55B
2.4B
1.28B
1.43B